Allergan plc. (AGN) Financial Statements (2024 and earlier)

Company Profile

Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
COOLOCK, DUBLIN, D17 E400
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2020
MRQ
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 5,9151,9074,63213,2261,105251
Cash and cash equivalents 2,5038801,8171,7241,096250
Short-term investments 3,4121,0272,81411,50291
Receivables 3,1922,8682,8992,5312,4022,372
Inventory, net of allowances, customer advances and progress billings 1,1338479057181,0102,076
Inventory 1,1338479057181,0102,076
Prepaid expense 449421712983265187
Deferred costs     36125
Disposal group, including discontinued operation     3,540949
Asset, held-for-sale, not part of disposal group  34   
Other undisclosed current assets 4373992,230400258922
Total current assets: 11,1276,47511,37717,8588,6156,882
Noncurrent Assets
Operating lease, right-of-use asset 490
Nontrade receivables 41     
Property, plant and equipment 1,9271,7871,7851,6111,5741,595
Long-term investments and receivables 7146729511210
Long-term investments 7146729511210
Intangible assets, net (including goodwill) 80,13989,609104,511108,975114,48343,710
Goodwill 42,24845,91349,86346,35646,55224,522
Intangible assets, net (excluding goodwill) 37,89143,69554,64862,61967,93219,188
Regulated entity, other noncurrent assets   122   
Disposal group, including discontinued operation, noncurrent assets     8,929 
Other noncurrent assets 15584513914854
Other undisclosed noncurrent assets 7503,7874244081,979279
Total noncurrent assets: 83,57295,312106,965111,128127,22545,647
TOTAL ASSETS: 94,699101,788118,342128,986135,84152,529
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 6,3494,7875,5415,0194,3504,171
Interest and dividends payable      83
Taxes payable      70
Employee-related liabilities      387
Accounts payable 390350325225369645
Accrued liabilities 5,9584,4375,2174,7943,9803,526
Other undisclosed accounts payable and accrued liabilities      (540)
Debt 4,5338684,2322,7982,433697
Restructuring reserve      125
Estimated litigation liability      415
Disposal group, including discontinued operation     1,490 
Deferred revenue and credits   27
Deferred tax liabilities   4747
Other undisclosed current liabilities 1907275589(464)
Total current liabilities: 11,0715,7289,8487,8758,3285,019
Noncurrent Liabilities
Long-term debt and lease obligation, including: 18,11722,92925,84429,97140,29314,846
Other undisclosed long-term debt and lease obligation 17,67022,92925,84429,97140,29314,846
Liabilities, other than long-term debt 8016,3847,23914,0549,3403,519
Deferred revenue and credits   39
Deferred tax liabilities, net5,5026,35212,9697,9863,062
Liability, pension and other postretirement and postemployment benefits      83
Disposal group, including discontinued operation, liabilities     92 
Other liabilities 8018828871,0851,262336
Operating lease, liability 446
Other undisclosed noncurrent liabilities 6,5151,6161,5748861,290810
Total noncurrent liabilities: 25,43230,92934,65744,91150,92319,175
Total liabilities: 36,50336,65744,50552,78659,25124,194
Equity
Equity, attributable to parent, including: 58,17465,11473,82176,19376,59128,331
Additional paid in capital 55,97556,51054,01453,95968,50828,995
Accumulated other comprehensive income (loss) 1,2071,3451,921(1,038)(494)(465)
Retained earnings (accumulated deficit) 9927,25912,95718,3433,648(198)
Other undisclosed equity, attributable to parent   4,9304,9304,930 
Equity, attributable to noncontrolling interest 2317168(2)4
Total equity: 58,19665,13173,83776,20176,58928,336
TOTAL LIABILITIES AND EQUITY: 94,699101,788118,342128,986135,84152,529

Income Statement (P&L) ($ in millions)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 16,08915,78715,94114,57115,07113,062
Revenue, net15,56814,36014,88713,062
Cost of revenue (6,015)(8,695)(7,548)(1,861)(4,810)(6,460)
Cost of goods and services sold (2,493)(2,191)(2,168)(1,861)(4,810)(6,460)
Gross profit: 10,0747,0938,39312,71010,2616,602
Operating expenses (14,520)(13,340)(14,314)(14,535)(13,327)(8,352)
Other undisclosed operating income     52482
Operating loss: (4,445)(6,248)(5,921)(1,826)(3,015)(1,268)
Nonoperating expense (673)(609)(4,465)(1,007)(1,416)(444)
Other nonoperating income (expense) 33257(3,437)219(234)(42)
Interest and debt expense (783)(30)(1,096)(1,296)(1,193)(382)
Loss from continuing operations before equity method investments, income taxes: (5,902)(6,887)(11,482)(4,128)(5,624)(2,094)
Income from equity method investments      6
Other undisclosed income from continuing operations before income taxes 783301,0961,2961,193376
Loss from continuing operations before income taxes: (5,119)(6,857)(10,386)(2,832)(4,430)(1,712)
Income tax expense (benefit) (146)1,7716,6701,8971,56282
Loss from continuing operations: (5,265)(5,086)(3,716)(935)(2,868)(1,630)
Income (loss) before gain (loss) on sale of properties: (5,265)(5,086)(4,119)14,9803,919(1,630)
Income (loss) from discontinued operations   (403)15,9156,788 
Net income (loss): (5,265)(5,086)(4,119)14,9803,919(1,630)
Net loss attributable to noncontrolling interest (6)(10)(7)(6)(4)(0)
Net income (loss) attributable to parent: (5,271)(5,096)(4,126)14,9733,915(1,631)
Preferred stock dividends and other adjustments  (46)(278)(278)(232) 
Net income (loss) available to common stockholders, diluted: (5,271)(5,143)(4,404)14,6953,683(1,631)

Comprehensive Income ($ in millions)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (5,265)(5,086)(4,119)14,9803,919(1,630)
Other comprehensive income (loss) (138)(513)2,959(544)(29)(556)
Comprehensive income (loss): (5,403)(5,599)(1,160)14,4353,891(2,186)
Comprehensive loss, net of tax, attributable to noncontrolling interest (6)(10)(7)(6)(4)(0)
Comprehensive income (loss), net of tax, attributable to parent: (5,409)(5,609)(1,166)14,4293,887(2,186)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: